Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk
December 31, 20203 min read653 words
Published: December 31, 2020  |  3 min read653 words
By , NEW YORK (Reuters) - Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United States on Jan. 1, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.The hikes come as d...
Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk Read more

No article scores yet.

There are no critic or public scores for this article yet.
critic reviews: 0
public reviews: 0
No reviews
img-trusted
100%
critic score
14 reviews
img-trusted
80%
public score
74 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
2 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.